Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment

Von Vergel L Torres1, Carrie F Coggon1, Timothy J Wells2

  • 1The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Australia.

Infection and Immunity
|February 9, 2021
PubMed

Insights

Antibody-dependent enhancement (ADE) can worsen bacterial infections, unlike its known viral counterpart. Research explores mechanisms and therapies, including plasmapheresis, to combat this antibody-mediated exacerbation of bacterial disease.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Antibody-dependent enhancement (ADE) is a known phenomenon in viral infections like flaviviruses and influenza.
  • The role of antibodies in exacerbating bacterial infections, termed bacterial ADE, is less understood.
  • Emerging evidence links antibodies to the worsening of bacterial disease in both experimental models and human patients.

Purpose of the Study:

  • To review historical evidence and molecular mechanisms of bacterial ADE.
  • To discuss current therapeutic strategies for bacterial ADE.
  • To highlight the potential of understanding bacterial ADE for infection management and vaccine development.

Main Methods:

  • Literature review of historical and recent studies on antibody-mediated enhancement of bacterial infections.
  • Analysis of disparate molecular mechanisms driving bacterial ADE compared to viral ADE.
  • Case study analysis of plasmapheresis as a therapeutic intervention for bacterial ADE.

Main Results:

  • Antibodies can enhance bacterial infections through mechanisms distinct from viral ADE.
  • Plasmapheresis has shown success in alleviating symptoms in patients with bacterial ADE.
  • Bacterial ADE presents unique challenges and requires specific understanding.

Conclusions:

  • A deeper comprehension of bacterial ADE is crucial for improved clinical management of bacterial infections.
  • Understanding bacterial ADE can inform the development of novel vaccines and therapeutic approaches.
  • Targeting antibody-mediated enhancement could be a key strategy in combating severe bacterial diseases.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.8K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
664
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
800
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.4K